Top medical experts in India are sounding the alarm over the misuse of GLP-1 drugs like Ozempic for lifestyle weight loss, ...

Prices for generic semaglutide, which also treats Type 2 diabetes, have reportedly decreased 70% to 90% in India.

Indian generic drugmakers launch a price war against Novo Nordisk’s GLP-1 brands, Ozempic and WeGovy.

March 24 (Reuters) - India's drug regulator has tightened surveillance against the unauthorised sale and promotion of ...

The Indian government announced on March 24 that it has intensified regulatory surveillance to combat the unauthorized sale ...

By Rishika Sadam HYDERABAD, March 19 (Reuters) - India's market for diabetes and weight-loss drugs is set for a shake-up as ...

Last week’s expiry of the patent for semaglutide—the active ingredient in Novo Nordisk’s blockbuster drugs Wegovy and Ozmepic ...

Half of US generic drugs are made in India and transit the Strait of Hormuz. Supply chains prepare for emergencies, but ...

The generic versions of semaglutide are expected to be at least 50% cheaper— ₹5,000 for a weekly dose—than Ozempic in India .

On any given morning in Mumbai’s Shivaji Park, power-walkers circle the running track, fitness watches buzzing with every step. Minutes later, some drift toward nearby food stalls, where oil sizzles ...

Replacing traditional weight management methods with GLP-1 medications can be effective for some, but it's essential to ...